PARP1 and cancer: As many natural compounds have shown important modulatory effects on PARP-1 but have not been clinically tested, neither in cancer nor in neurodegeneration, it is important to remember that cell death is the ultimate desirable goal of anticancer therapies, while it is the ultimate fatal condition to avoid in neurodegeneration.